SUPPLEMENT

Q2 2025 — Financial statement information

Q2 2025PDF · 15 pages309 KB
Three months ended
June 30,
Six months ended
June 30,
2025 2024 2025 2024
Net sales $ 6,344 $ 6,255 $ 12,298 $ 12,271
Operating expenses
Cost of sales 3,646 3,571 7,124 7,056
Selling, general and administrative expenses 1,267 1,132 2,212 2,260
Research, development and related expenses 288 280 573 534
Loss on business divestitures 3 — 3 —
Total operating expenses 5,204 4,983 9,912 9,850
Operating income 1,140 1,272 2,386 2,421
Other expense (income), net 217 (138) 78 82
Income from continuing operations before income taxes 923 1,410 2,308 2,339
Provision for income taxes 245 203 510 423
Income from continuing operations of consolidated group 678 1,207 1,798 1,916
Income from unconsolidated subsidiaries, net of taxes 47 3 49 4
Net income from continuing operations including noncontrolling interest 725 1,210 1,847 1,920
Less: net income attributable to noncontrolling interest 2 6 8 11
Net income from continuing operations attributable to 3M 723 1,204 1,839 1,909
Net income (loss) from discontinued operations, net of taxes — (59) — 164
Net income attributable to 3M $ 723 $ 1,145 $ 1,839 $ 2,073
Earnings per share attributable to 3M common shareholders:
Weighted average 3M common shares outstanding — basic 537.4 553.8 540.6 554.4
Earnings per share from continuing operations — basic $ 1.35 $ 2.17 $ 3.40 $ 3.44
Earnings (loss) per share from discontinued operations — basic — (0.10) — 0.30
Earnings per share — basic $ 1.35 $ 2.07 $ 3.40 $ 3.74
Weighted average 3M common shares outstanding — diluted 540.6 554.8 544.2 555.3
Earnings per share from continuing operations — diluted $ 1.34 $ 2.17 $ 3.38 $ 3.44
Earnings (loss) per share from discontinued operations — diluted — (0.10) — 0.29
Earnings per share — diluted $ 1.34 $ 2.07 $ 3.38 $ 3.73
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)
1

-- 1 of 15 --

June 30, 2025 December 31, 2024
Assets
Current assets
Cash and cash equivalents $ 3,712 $ 5,600
Marketable securities – current 502 2,128
Accounts receivable – net 3,760 3,194
Inventories 4,077 3,698
Prepaids 642 493
Other current assets 734 771
Total current assets 13,427 15,884
Property, plant and equipment – net 7,393 7,388
Operating lease right of use assets 573 565
Goodwill and intangible assets – net 7,595 7,491
Other assets 9,001 8,540
Total assets $ 37,989 $ 39,868
Liabilities and equity
Current liabilities
Short-term borrowings and current portion of long-term debt $ 669 $ 1,919
Accounts payable 2,840 2,660
Accrued payroll 594 712
Accrued income taxes 315 331
Operating lease liabilities – current 180 163
Other current liabilities 3,210 5,471
Total current liabilities 7,808 11,256
Long-term debt 12,477 11,125
Other liabilities 13,353 13,593
Total liabilities 33,638 35,974
Total equity 4,351 3,894
Shares outstanding
June 30, 2025: 532,629,702
December 31, 2024: 539,470,303
Total liabilities and equity $ 37,989 $ 39,868
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
2

-- 2 of 15 --

Six months ended June 30,
2025 2024
Net cash provided by (used in) operating activities $ (1,033) $ 1,788
Cash flows from investing activities:
Purchases of property, plant and equipment (444) (644)
Purchases and proceeds from sale or maturities of marketable
securities and investments – net 1,711 (236)
Proceeds from sale of businesses, net of cash sold 5 —
Other investing activities 18 24
Net cash provided by (used in) investing activities 1,290 (856)
Cash flows from financing activities:
Change in debt – net (151) 5,509
Purchases of treasury stock (2,227) (421)
Proceeds from issuances of treasury stock pursuant to stock option and
benefit plans 988 30
Dividends paid to shareholders (786) (1,221)
Cash transferred to Solventum related to separation, net — (577)
Other financing activities (15) (57)
Net cash provided by (used in) financing activities (2,191) 3,263
Effect of exchange rate changes on cash and cash equivalents 46 (45)
Net increase (decrease) in cash and cash equivalents (1,888) 4,150
Cash and cash equivalents at beginning of year 5,600 5,933
Cash and cash equivalents at end of period $ 3,712 $ 10,083
The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash
and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of
discontinued operations in the 3M Consolidated Balance Sheet.
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
3

-- 3 of 15 --

Three months ended June 30, 2025
Sales change analysis by geographic area Americas Asia Pacific Europe, Middle East
and Africa Worldwide
Organic sales 0.6 % 2.3 % (2.3) % 0.6 %
Translation (0.6) 1.3 4.8 0.8
Total sales change — % 3.6 % 2.5 % 1.4 %
Six months ended June 30, 2025
Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East
and Africa Worldwide
Organic sales 1.1 % 0.8 % (3.7) % 0.2 %
Divestitures 0.7 0.1 0.3 0.5
Translation (0.9) (0.4) 1.2 (0.5)
Total sales change 0.9 % 0.5 % (2.2) % 0.2 %
Three months ended June 30, 2025
Worldwide sales change by business segment Organic sales Divestitures Translation Total sales
change
Safety and Industrial 2.6 % — % 1.0 % 3.6 %
Transportation and Electronics (1.5) (0.1) 1.0 (0.6)
Consumer 0.3 — 0.3 0.6
Six months ended June 30, 2025
Worldwide Sales Change By Business Segment Organic sales Divestitures Translation Total sales
change
Safety and Industrial 2.5 % — % (0.5) % 2.0 %
Transportation and Electronics (2.8) — (0.2) (3.0)
Consumer 0.3 — (0.7) (0.4)
2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales,
acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition
and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months
post-transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS2
(Unaudited)
4

-- 4 of 15 --

3M discloses business segment operating income as its measure of segment profit, reconciled to both total 3M operating income
and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to
business segments (as described below in “Corporate and Other”).
Three months ended
June 30, Six months ended
June 30,
Net sales (millions) 2025 2024 2025 2024
Abrasives $ 338 $ 324 $ 655 $ 652
Automotive Aftermarket 291 304 581 610
Electrical Markets 349 319 674 624
Industrial Adhesives and Tapes 568 531 1,111 1,049
Industrial Specialties Division 294 291 582 581
Personal Safety 882 857 1,732 1,714
Roofing Granules 135 133 267 261
Total Safety and Industrial business segment 2,857 2,759 5,602 5,491
Advanced Materials 227 244 445 507
Automotive and Aerospace 474 481 949 987
Commercial Branding and Transportation 689 672 1,305 1,282
Electronics 740 746 1,421 1,471
Total Transportation and Electronics business segment 2,130 2,143 4,120 4,247
Consumer Safety and Well-Being 280 280 554 546
Home and Auto Care 306 302 605 607
Home Improvement 374 369 700 699
Packaging and Expression 310 312 535 551
Total Consumer business segment 1,270 1,263 2,394 2,403
Total reportable business segments 6,257 6,165 12,116 12,141
Corporate and Other 87 90 182 130
Total company $ 6,344 $ 6,255 $ 12,298 $ 12,271
Operating income (millions)
Safety and Industrial $ 721 $ 612 $ 1,417 $ 1,269
Transportation and Electronics 462 428 814 909
Consumer 268 219 487 435
Total reportable business segments 1,451 1,259 2,718 2,613
Corporate and Other
Corporate special items:
Net costs for significant litigation (330) (8) (401) (71)
Divestiture costs — (14) — (20)
Loss on business divestitures (3) — (3) —
Total corporate special items (333) (22) (404) (91)
Other corporate (expense) income - net 22 35 72 (101)
Total Corporate and Other (311) 13 (332) (192)
Total company operating income 1,140 1,272 2,386 2,421
Other expense/(income), net 217 (138) 78 82
Income from continuing operations before income taxes $ 923 $ 1,410 $ 2,308 $ 2,339
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
5

-- 5 of 15 --

Corporate and Other
Outside of 3M's reportable operating segments, 3M has Corporate and Other which is not a reportable business segment as it
does not meet the segment reporting criteria. Because Corporate and Other includes a variety of miscellaneous items, it is
subject to fluctuation on a quarterly and annual basis.
Corporate and Other operating income (loss) includes:
• Corporate special items includes, for the periods presented:
◦ net costs for significant litigation impacting operating income (loss) associated with PFAS-related other
environmental and Combat Arms Earplugs matters.
◦ loss on business divestitures.
◦ divestiture costs (related to separating and divesting substantially an entire business segment of 3M following
public announcement of its intended divestiture) that were not eligible to be part of discontinued operations.
• Other corporate (expense) income-net includes:
◦ certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs
that 3M may choose not to allocate directly to its business segments.
◦ commercial activity with Solventum following its April 1, 2024 Separation and certain operations of the
former Health Care business segment retained by 3M.
◦ transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested
businesses, including those related to the Solventum Separation.
◦ operations of businesses of the former Health Care segment divested prior to the Separation and therefore not
reflected as discontinued operations within 3M's financial statements, along with limited-duration supply
agreements with previous divestitures.
◦ costs previously allocated to Solventum prior to the Separation that were not eligible to be part of
discontinued operations.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
6

-- 6 of 15 --

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These
measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly
titled measures used by other companies.
Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in
the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments,
it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Other, except as described
with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items”
section. The reconciliations below, therefore, also include impacted segments as applicable.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for
special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and
reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for
special items is also provided: Reasons 3M believes the measure is useful:
• Net sales (and sales change)
Considered, in addition to segment operating performance, in
evaluating and managing operations; useful in understanding
underlying business performance, provides additional transparency to
special items
• Operating income (loss), segment operating
income (loss) and operating income (loss) margin
• Other expense (income), net
• Income from continuing operations before taxes
• Provision for income taxes and effective tax rate
• Net income from continuing operations
• EPS from continuing operations
Additional non-GAAP measures:
• Adjusted net cash provided by (used in)
operating activities; adjusted purchases of
property, plant and equipment (also referred to as
adjusted capital expenditures); adjusted free cash
flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as
indicator of capital deployment; meaningful as measures of
performance
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
7

-- 7 of 15 --

Certain amounts adjusted for special items (non-GAAP measures):
Three months ended June 30, 2024
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Operating
income
Operating
income
margin
Income
before taxes
Provision
for income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
Safety and Industrial
GAAP amounts $ 612 22.2 %
Adjustments for special items:
Net costs for significant litigation 11
Total special items 11
Adjusted amounts (non-GAAP measures)3 $ 623 22.6 %
Transportation and Electronics
GAAP amounts $ 2,143 $ 428 20.0 %
Adjustments for special items:
Manufactured PFAS products (236) (2)
Total special items (236) (2)
Adjusted amounts (non-GAAP measures)3 $ 1,907 $ 426 22.3 %
Total company
GAAP amounts $ 6,255 $ 1,272 20.3 % $ 1,410 $ 203 14.4 % $ 1,204 $ 2.17
Adjustments for special items:
Net costs for significant litigation — 19 221 (25) 246 0.44
Divestiture costs — 14 14 (113) 127 0.23
Manufactured PFAS products (236) (2) (2) (1) (1) —
Pension risk transfer charge — — 795 188 607 1.09
Solventum ownership - change in value — — (1,113) — (1,113) (2.00)
Total special items (236) 31 (85) 49 (134) (0.24)
Adjusted amounts (non-GAAP measures)3 $ 6,019 $ 1,303 21.6 % $ 1,325 $ 252 19.1 % $ 1,070 $ 1.93
Three months ended June 30, 2025
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Sales
change
Operating
income
Operating
income
margin
Income
before
taxes
Provision
for
income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
EPS
percent
change
Safety and Industrial
GAAP amounts $ 721 25.3 %
Adjustments for special items:
Net costs for significant litigation 17
Adjusted amounts (non-GAAP measures)3 $ 738 25.8 %
Transportation and Electronics
GAAP amounts $ 2,130 (0.6) % $ 462 21.7 %
Adjustments for special items:
Manufactured PFAS products (186) 17
Adjusted amounts (non-GAAP measures)3 $ 1,944 1.9 % $ 479 24.6 %
Total company
GAAP amounts $ 6,344 1.4 % $ 1,140 18.0 % $ 923 $ 245 26.6 % $ 723 $ 1.34 (38) %
Adjustments for special items:
Net costs for significant litigation — 347 471 46 425 0.79
Loss on business divestitures — 3 3 1 2 —
Manufactured PFAS products (186) 17 17 4 13 0.02
Solventum ownership - change in value — — 7 — 7 0.01
Total special items (186) 367 498 51 447 0.82
Adjusted amounts (non-GAAP measures)3 $ 6,158 2.3 % $ 1,507 24.5 % $ 1,421 $ 296 20.8 % $ 1,170 $ 2.16 12 %
3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
8

-- 8 of 15 --

Six months ended June 30, 2024
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Operating
income
Operating
income
margin
Income
before taxes
Provision
for income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
Safety and Industrial
GAAP amounts $ 1,269 23.1 %
Adjustments for special items:
Net costs for significant litigation 18
Adjusted amounts (non-GAAP measures)3 $ 1,287 23.4 %
Transportation and Electronics
GAAP amounts $ 4,247 $ 909 21.4 %
Adjustments for special items:
Manufactured PFAS products (517) (4)
Adjusted amounts (non-GAAP measures)3 $ 3,730 $ 905 24.3 %
Total Company
GAAP amounts $ 12,271 $ 2,421 19.7 % $ 2,339 $ 423 18.1 % $ 1,909 $ 3.44
Adjustments for special items:
Net costs for significant litigation — 89 495 6 489 0.88
Divestiture costs — 20 20 (111) 131 0.24
Manufactured PFAS products (517) (4) (4) (2) (2) —
Pension risk transfer charge — — 795 188 607 1.09
Solventum ownership - change in value — — (1,113) — (1,113) (2.01)
Total special items (517) 105 193 81 112 0.20
Adjusted amounts (non-GAAP measures)3 $ 11,754 $ 2,526 21.5 % $ 2,532 $ 504 19.9 % $ 2,021 $ 3.64
Six months ended June 30, 2025
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Sales
change
Operating
income
Operating
income
margin
Income
before
taxes
Provision
for
income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
EPS
percent
change
Safety and Industrial
GAAP amounts $ 1,417 25.3 %
Adjustments for special items:
Net costs for significant litigation 20
Adjusted amounts (non-GAAP measures)3 $ 1,437 25.7 %
Transportation and Electronics
GAAP amounts $ 4,120 (3.0) % $ 814 19.8 %
Adjustments for special items:
Manufactured PFAS products (360) 55
Adjusted amounts (non-GAAP measures)3 $ 3,760 0.8 % $ 869 23.1 %
Total Company
GAAP amounts $ 12,298 0.2 % $ 2,386 19.4 % $ 2,308 $ 510 22.1 % $ 1,839 $ 3.38 (2) %
Adjustments for special items:
Net costs for significant litigation — 421 695 44 651 1.20
Loss on business divestitures — 3 3 1 2 —
Manufactured PFAS products (360) 55 55 13 42 0.08
Solventum ownership - change in value — — (336) — (336) (0.62)
Total special items (360) 479 417 58 359 0.66
Adjusted amounts (non-GAAP measures)3 $ 11,938 1.6 % $ 2,865 24.0 % $ 2,725 $ 568 20.9 % $ 2,198 $ 4.04 11 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
9

-- 9 of 15 --

2025 forecast
2025 adjusted earnings per share from continuing operations (non-GAAP measure)3,4 $7.75 to $8.00
43M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or
provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant
litigation; projected divestiture gains (losses); divestiture costs; divestiture-related restructuring; changes in value of Solventum
ownership; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject
to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these
limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that
the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-
divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction. Information with
respect to special items for certain historical periods is included in the section entitled “Description of special items”.
Three months ended June 30, 2025
Sales change2
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total company 0.6 % — % — % 0.8 % 1.4 %
Remove manufactured PFAS products special item impact 0.9 — — — 0.9
Adjusted total company (non-GAAP measures)3 1.5 % — % — % 0.8 % 2.3 %
Transportation and Electronics (1.5) % — % (0.1) % 1.0 % (0.6) %
Remove manufactured PFAS products special item impact 2.5 — — — 2.5
Adjusted Transportation and Electronics (non-GAAP measures)3 1.0 % — % (0.1) % 1.0 % 1.9 %
By Geographic Area
Americas 0.6 % — % — % (0.6) % — %
Remove manufactured PFAS products special item impact 0.4 — — — 0.4
Adjusted Americas (non-GAAP measures)3 1.0 % — % — % (0.6) % 0.4 %
Asia Pacific 2.3 % — % — % 1.3 % 3.6 %
Remove manufactured PFAS products special item impact 1.2 — — (0.1) 1.1
Adjusted Asia Pacific (non-GAAP measures)3 3.5 % — % — % 1.2 % 4.7 %
Europe, Middle East & Africa (2.3) % — % — % 4.8 % 2.5 %
Remove manufactured PFAS products special item impact 2.1 — — 0.2 2.3
Adjusted Europe, Middle East & Africa (non-GAAP measures)3 (0.2) % — % — % 5.0 % 4.8 %
By Particular Country
United States 0.3 % — % — % — % 0.3 %
Remove manufactured PFAS products special item impact 0.4 — — — 0.4
Adjusted United States (non-GAAP measures)3 0.7 % — % — % — % 0.7 %
China 5.8 % — % — % 0.2 % 6.0 %
Remove manufactured PFAS products special item impact 0.1 — — (0.1) —
Adjusted China (non-GAAP measures)3 5.9 % — % — % 0.1 % 6.0 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
10

-- 10 of 15 --

Six months ended June 30, 2025
Sales Change2
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company 0.2 % — % 0.5 % (0.5) % 0.2 %
Remove manufactured PFAS products special item impact 1.3 — — 0.1 1.4
Adjusted total Company (non-GAAP measures)3 1.5 % — % 0.5 % (0.4) % 1.6 %
Transportation and Electronics (2.8) % — % — % (0.2) % (3.0) %
Remove manufactured PFAS products special item impact 3.8 — — — 3.8
Adjusted Transportation and Electronics (non-GAAP measures)3 1.0 % — % — % (0.2) % 0.8 %
By Geographic Area
Americas 1.1 % — % 0.7 % (0.9) % 0.9 %
Remove manufactured PFAS products special item impact 0.3 — 0.1 (0.2) 0.2
Adjusted Americas (non-GAAP measures)3 1.4 % — % 0.8 % (1.1) % 1.1 %
Asia Pacific 0.8 % — % 0.1 % (0.4) % 0.5 %
Remove manufactured PFAS products special item impact 2.5 — — — 2.5
Adjusted Asia Pacific (non-GAAP measures)3 3.3 % — % 0.1 % (0.4) % 3.0 %
Europe, Middle East & Africa (3.7) % — % 0.3 % 1.2 % (2.2) %
Remove manufactured PFAS products special item impact 2.8 — — 0.1 2.9
Adjusted Europe, Middle East & Africa (non-GAAP measures)3 (0.9) % — % 0.3 % 1.3 % 0.7 %
By Particular Country
United States 0.6 % — % 0.9 % — % 1.5 %
Remove manufactured PFAS products special item impact 0.2 — 0.1 — 0.3
Adjusted United States (non-GAAP measures)3 0.8 % — % 1.0 % — % 1.8 %
China 4.7 % — % 0.2 % (0.3) % 4.6 %
Remove manufactured PFAS products special item impact 0.8 — — — 0.8
Adjusted China (non-GAAP measures)3 5.5 % — % 0.2 % (0.3) % 5.4 %
2025 forecast
Sales Change2 Organic sales Acquisitions Divestitures Translation Total sales change
Total Company4 ~2.0% — % ~0.5% — % ~2.5%
Remove manufactured PFAS products impact4 — — — — —
Adjusted total company (non-GAAP measures)3,4 ~2.0% — % ~0.5% — % ~2.5%
Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also
referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-
GAAP measures):
Three months ended
June 30, Six months ended
June 30,
Major GAAP cash flow categories (dollars in millions) 2025 2024 2025 2024
Net cash provided by (used in) operating activities $ (954) $ 1,021 $ (1,033) $ 1,788
Net cash provided by (used in) investing activities 70 (463) 1,290 (856)
Net cash provided by (used in) financing activities (1,769) (1,358) (2,191) 3,263
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
11

-- 11 of 15 --

Three months ended
June 30, Six months ended
June 30,
Adjusted free cash flow (non-GAAP measure) (dollars in millions) 2025 2024 2025 2024
Net cash provided by (used in) operating activities $ (954) $ 1,021 $ (1,033) $ 1,788
Adjustments for special items:
Net costs for significant litigation after-tax payment impacts 2,216 122 3,003 473
Divestiture costs after-tax payment impacts 43 136 59 275
Divestiture-related restructuring after-tax payment impacts — 1 — 2
TCJA transition tax payment 211 193 211 193
Manufactured PFAS products impact after-tax payment impacts (25) (58) (32) (128)
Total adjustments for special items 2,445 394 3,241 815
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)5 $ 1,491 $ 1,415 $ 2,208 $ 2,603
Purchases of property, plant and equipment (PPE) (208) (269) (444) (644)
Manufactured PFAS products impact - removing related purchases of PPE 1 19 9 39
Adjusted purchases of PPE (non-GAAP measure)5 $ (207) $ (250) $ (435) $ (605)
Adjusted free cash flow (non-GAAP measure)5 $ 1,284 $ 1,165 $ 1,773 $ 1,998
Net income attributable to 3M $ 723 $ 1,145 $ 1,839 $ 2,073
Adjustments for special items, net of tax:
Net costs for significant litigation 425 246 651 489
Manufactured PFAS products impact 13 (1) 42 (2)
Loss on business divestitures 2 — 2 —
Divestiture costs — 184 — 341
Solventum ownership - change in value 7 (1,113) (336) (1,113)
Pension risk transfer charge — 607 — 607
Total adjustments for special items, net of tax 447 (77) 359 322
Net income attributable to 3M adjusted for special items
(used for adjusted free cash flow conversion calculation)
$ 1,170 $ 1,068 $ 2,198 $ 2,395
Adjusted free cash flow conversion (non-GAAP measure)5 110 % 109 % 81 % 83 %
53M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations (Solventum separated from 3M
in April 2024); accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued
operations in certain periods both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating
activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and
equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated
impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash
provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the
determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the
portion of payments of costs for significant litigation under the 2023 and 2025 settlement/proposed settlement agreements relative to Combat
Arms Earplugs and relative to public water systems and the state of New Jersey regarding PFAS is based on the timing/amount of the actual
cash tax deduction (which differs from the timing of the pre-tax cash settlement payments). The impacts of certain tax-related divestiture costs
are based on applicable tax rates and the timing of tax payments relative to underlying Separation transactions. For other special items, the
cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. Tax impacts include associated
impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of
repatriation. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income (loss) attributable to 3M,
adjusted for special items (used for adjusted free cash flow conversion calculation).
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
12

-- 12 of 15 --

(Dollars in billions) 2025 forecast
Net cash provided by (used in) operating activities $5.1 to $5.5
Adjustments for special items4 —
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)4,5 $5.1 to $5.5
Purchase of property, plant and equipment (PPE) (~$1.0)
Manufactured PFAS products impact — removing related purchases of PPE 0.1
Adjusted purchases of PPE (non-GAAP measure)5 (~$0.9)
Adjusted free cash flow (non-GAAP measure)4,5 $4.2 to $4.5
Net income attributable to 3M $4.2 to $4.3
Adjustments for special items4 —
Adjusted net income attributable to 3M (non-GAAP measure)3,4 $4.2 to $4.3
Adjusted free cash flow conversion (non-GAAP measure)4,5 >100%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
13

-- 13 of 15 --

Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other
environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities
(including interest imputation on applicable settlement obligations), legal costs, and insurance recoveries, along with the
associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible
Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits and tax costs of repatriation. 3M does
not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the
Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment.
Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment
while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms
Earplugs matters are reflected as corporate special items in Corporate and Other. In the second quarter of 2025 and 2024,
3M reflected net pre-tax cash (receipts)/payments of $2,509 million and $428 million, respectively, related to net costs for
significant litigation. In the first six months of 2025 and 2024, 3M reflected net pre-tax cash (receipts)/payments of $3,315
million and $799 million, respectively, related to net costs for significant litigation.
Loss on business divestitures:
• In June 2025, 3M completed a divestiture for immaterial proceeds slightly below the business's book value .
Divestiture costs:
• These include certain limited costs that were not eligible to be included within discontinued operations related to
separating and divesting substantially an entire business segment of 3M following public announcement of its intended
divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of updating
3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close
and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and discontinued
operations. Therefore, in the context of amounts used in the determination of non-GAAP measures associated with cash
flow and adjusted free cash flow conversion, this special item further includes the broader extent of such costs that
included within discontinued operations, including interest expense on debt issued by Solventum for the period
outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of entity
structuring associated with the separation of Solventum. In the second quarter and first six months of 2024, 3M made pre-
tax cash payments of $58 million and $192 million, respectively, associated with divestiture costs.
Divestiture-related restructuring actions:
• In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to
undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of
amounts previously allocated to the divested business. In the first six months of 2024, 3M made pre-tax cash payments of
$2 million associated with divestiture-related restructuring actions.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA):
• In the second quarter of 2025 and 2024, 3M made payments of $211 million and $193 million, respectively, related to the
transition tax expense incurred as a result of the 2017 enactment of the TCJA.
Manufactured PFAS products:
• These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS
products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment.
Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-
service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of
manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of
associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated
payments.
Solventum ownership - change in value:
• This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in
other expense (income), net.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
14

-- 14 of 15 --

Pension risk transfer charge:
• In 2024, primarily in the second quarter, 3M recorded a non-cash pension settlement charge reflected in other expense
(income), net as a result of transferring a portion of its U.S. pension payment obligations and related plan assets to an
insurance company.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
15

-- 15 of 15 --